Clinical Study
Tuboovarian Abscesses: Is Size Associated with Duration of Hospitalization & Complications?
Table 3
Outcomes and initial antibiotic regimen by abscess size.
| | All patients ( = 135) | Abscess ≤8 cm ( = 112) | Abscess >8 cm ( = 23) | P-value |
| # days hospitalized mean (SD) | 4.6 (3.6) | 4.4 (3.4) | 5.7 (4.2) | .09 |
| # days febrile (>38.2) | 1.1 (1.8) | 1.10 (1.6) | 1.35 (2.5) | .65 |
| (%) | | | | |
| Requiring drainage/surgery | 42 (31%) | 32 (29%) | 10 (43%) | .16 | Drainage | 11 (8%) | 9 (8%) | 2 (9%) | .31 | Surgery | 34 (25%) | 26 (23%) | 8 (35%) | .24 |
| Number of antibiotics used, mean (SD) | 2.8 (1.2) | 2.7 (1.2) | 3.1 (1.3) | .20 |
| Antibiotic regimen | | | | | Cefoxitin and doxycycline | 57 (43%) | 50 (45%) | 7 (30%) | .14 | Ciprofloxacin and Flagyl | 11 (8%) | 7 (6%) | 4 (17%) | | Gentamicin and clindamycin | 18 (14%) | 13 (12%) | 5 (22%) | | Other | 46 (35%) | 39 (35%) | 7 (30%) | |
| Any complication | 18 (13%) | 10 (9%) | 8 (35%) | <.01 |
|
|
-value estimated from Fisher’s exact test.
|